Cargando…
A genetic model for central chondrosarcoma evolution correlates with patient outcome
BACKGROUND: Central conventional chondrosarcoma (CS) is the most common subtype of primary malignant bone tumour in adults. Treatment options are usually limited to surgery, and prognosis is challenging. These tumours are characterised by the presence and absence of IDH1 and IDH2 mutations, and rece...
Autores principales: | Cross, William, Lyskjær, Iben, Lesluyes, Tom, Hargreaves, Steven, Strobl, Anna-Christina, Davies, Christopher, Waise, Sara, Hames-Fathi, Shadi, Oukrif, Dahmane, Ye, Hongtao, Amary, Fernanda, Tirabosco, Roberto, Gerrand, Craig, Baker, Toby, Barnes, David, Steele, Christopher, Alexandrov, Ludmil, Bond, Gareth, Cool, Paul, Pillay, Nischalan, Loo, Peter Van, Flanagan, Adrienne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426036/ https://www.ncbi.nlm.nih.gov/pubmed/36042521 http://dx.doi.org/10.1186/s13073-022-01084-0 |
Ejemplares similares
-
Drivers underpinning the malignant transformation of giant cell tumour of bone
por: Fittall, Matthew W, et al.
Publicado: (2020) -
H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours
por: Lyskjær, Iben, et al.
Publicado: (2020) -
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations
por: Lyskjær, Iben, et al.
Publicado: (2021) -
Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways
por: Steele, Christopher D., et al.
Publicado: (2019) -
DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’
por: Lyskjær, Iben, et al.
Publicado: (2021)